Temporal changes in quality of life after prostate carcinoma;Zeitlicher verlauf der lebensqualität nach prostatakarzinom

Urologe - Ausgabe A

Volumn 51, Issue 5, 2012, Pages 706-712

  Perl, M ^a   Waldmann, A ^b   Pritzkuleit, R ^a   Katalinic, A ^a,b  

^a Institut für Krebsepidemiologie E V   (Germany)

^b Institut Für Sozialmedizin Und Epidemiologie   (Germany)

Author keywords

Decision making in therapy; OVIS study; Predictors; Prostate cancer; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PROSTATE CARCINOMA; QUALITY OF LIFE; SOCIAL CLASS;

AGED; GERMANY; HEALTH STATUS; HUMANS; MALE; PREVALENCE; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 84863784108     PISSN: 03402592     EISSN: 14330563     Source Type: Journal    
DOI: 10.1007/s00120-011-2788-z     Document Type: Article

References (23)

1. Bestmann B, Loetters C, Diemer T et al (2007) Prostate-specific symptoms of prostate cancer in a German general population. Prostate Cancer Prostatic Dis 10:52-59 (Pubitemid 46358911)
2. Deck R (2008) Soziale Ungleichheit in der medizinischen Rehabilitation. Gesundheitswesen 70:582-589
3. Deck R, Röckelein E (1999) Zur Erhebung soziodemographischer und sozialmedizinscher Indikatoren in den rehabilitationswissenschaftlichen Forschungsverbünden. DRV-Schriften, Bd. 16 Förderschwerpunkt "Rehabilitationswissenschaften"; Empfehlungen der Arbeitsgruppen "generische Methoden", "Routinedaten", und "Reha-Ökonomie" Verband Deutsche Rentenversicherungsträger (Hrsg), Frankfurt am Main
4. Fayers P, Aaronson N, Bjordal K et al (2001) The EORTC QLQ-C30 scoring manual. European Organization for Research and Treatment of Cancer, Brussels
5. Hakamies-Blomquist L, Louma ML, Sjoestroem J et al (2001) Timing of quality of life (QoL) assessments as a source of error in oncological trails. J Adv Nurs 35:709-716
6. Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53:68-80 (Pubitemid 350166735)
7. Jønler M, Nielsen OS, Groenvold M et al (2005) Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group study Scandinavian J Urol Nephrol 39:42-48 (Pubitemid 40380442)
8. Korfage IJ, de Koning HJ, Habbema JD et al (2007) Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls? BJU Int 99:801-806 (Pubitemid 46439579)
9. Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144 (Pubitemid 28041591)
10. Rees J, Clarke MG, Waldron D et al (2005) The measurement of response shift in patients with advanced prostate cancer and their partners. Health Qual Life Outcomes 3:21
11. Repetto L, Ausili-Cefaro G, Rossi A, Manzione L (2001) Quality of life in elderly cancer patients. Ann Oncol 12:49-52
12. Robert Koch-Institut, Gesellschaft epidemiologischer Krebsregister in Deutschland (2010) Krebs in Deutschland 2005/ Häufigkeiten und Trends. Westkreuz-Druckerei, Berlin
13. Rohde V, Wasem J, Katalinic A (2007) Gesundheitsberichterstattung des Bundes, Heft 36: Prostataerkrankungen. RKI, Berlin
14. Sanda MG, Dunn RL, Michalski J et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358:1250-1261 (Pubitemid 351439226)
15. Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37:1345-1351 (Pubitemid 32588744)
16. Sprangers MA, Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48:1507-1515 (Pubitemid 29254110)
17. Sullivan PW, Mulani PM, Fishman M, Sleep D (2007) Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer. Qual Life Res 16:571-575 (Pubitemid 46474953)
18. Ubel PA, Loewenstein G, Jepson C (2003) Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res 12:599-607 (Pubitemid 37094023)
19. Waldmann A, Dreckschmidt J, Pritzkuleit R, Katalinic A (2010) Reliabilität des OVIS-Fragebogens - ein Instrument zur Evaluation der onkologischen Versorgung aus Patientensicht. Gesundheitswesen 72:707-713
20. Waldmann A, Rohde V, Bremner K et al (2009) Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P). BMC Cancer 9:295
21. Waldmann A, Rohde V, Kuechler T, Katalinic A (2009) German version of PORPUS-P: reference values, reliability, construct validity, discriminant and concurrent validity. In: Hoffmann E (Hrsg) Health related quality of life. Public Health in the 21st Century. Nova Biomedical Books, New York, pp 85-104
22. Zhou ES, Penedo FJ, Bustillo NE et al (2010) Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer. J Support Oncol 8:196-201
23. Zhou ES, Penedo FJ, Lewis JE et al (2007) Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer. J Psychosom Res 69:587-590